Takeda Pharmaceuticals: Advancing Healthcare Innovation from Tokyo, Japan

Takeda Pharmaceutical Company Limited stands as a global biopharmaceutical leader headquartered in Tokyo, Japan, with a legacy spanning over 230 years. The company is dedicated to bringing better health and a brighter future to people worldwide through science-driven innovation and a patient-centered approach.

Founded in 1781 in Doshomachi, Osaka, by Chobei Takeda I, Takeda has evolved into a multinational corporation with operations in approximately 80 countries. Its global headquarters is located in Nihonbashi, Chuo-ku, Tokyo, at 1-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103-8668, Japan. The company maintains a significant presence in key markets, including Japan and the United States, where it holds leading positions in two of the world’s largest pharmaceutical markets.

As a research and development (R&D)-driven organization, Takeda focuses on discovering and delivering life-transforming treatments across therapeutic areas such as oncology, gastroenterology, neuroscience, and rare diseases. The company’s commitment to innovation is exemplified by recent advancements like Zasocitinib, an oral medication that demonstrated rapid and durable skin clearance in psoriasis patients, reinforcing its promise to reshape psoriasis care.

Takeda continues to strengthen its competitiveness through strategic transformation initiatives aimed at accelerating future growth. In March 2026, the company announced next steps in its transformation to enhance competitiveness and support sustainable, patient-centered growth. These efforts include leadership updates, with candidates for the Board of Directors and changes in representative director being presented at the upcoming shareholders meeting.

Beyond pharmaceutical innovation, Takeda invests in digital advancement to improve patient outcomes. On March 6, 2026, the company launched the Takeda Japan Innovation Center (TJIC) at its Tokyo headquarters, underscoring its commitment to staying at the forefront of digital healthcare solutions.

Guided by its core values and a heritage of integrity, Takeda remains focused on translating science into tangible benefits for patients. The company collaborates with globally diverse teams to advance medical science and expand access to transformative care, reinforcing its mission to create better health for people and a brighter future for the world.

For more information about Takeda’s initiatives, pipeline, and corporate responsibility efforts, visit the company’s official global website.